For example, the molecular diagnosis of monogenic diabetes can lead to changes in treatment, often with improved glycemic control, as some patients with monogenic diabetes carrying mutations in specific genes (e.g., HNF1A, HNF4A, KCNJ11, and ABCC8) can be treated with oral sulfonylureas instead of insulin [34]. Here, KCNJ11 is linked to diabetes mellitus.